CG Oncology Inc.
CGON | NASDAQ
$78.25
+$3.63 (+4.86%)
At close: Sep 21, 2026, 4:00 PM ET
$78.23
-$0.02 (-0.03%)
Pre-market:
Sep 22, 2026, 6:00 AM ET
TTM Period Ending | TTM 2026 Jun 29, 2026 | TTM 2026 Mar 30, 2026 | TTM 2025 Dec 30, 2025 | TTM 2025 Sep 29, 2025 | TTM 2025 Jun 29, 2025 | TTM 2025 Mar 30, 2025 | TTM 2024 Dec 30, 2024 | TTM 2024 Sep 29, 2024 | TTM 2024 Jun 29, 2024 | TTM 2024 Mar 30, 2024 | TTM 2023 Dec 30, 2023 | TTM 2023 Sep 29, 2023 | TTM 2023 Jun 29, 2023 | TTM 2022 Dec 30, 2022 | TTM 2021 Dec 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -26.31 | -28.92 | -19.96 | -19.65 | -14.61 | -16.11 | -21.73 | -32.53 | -27.82 | -41.51 | -40.85 | -52.35 | -86.44 | -56.32 | -132.75 |
PEG Ratio | -0.98 | -0.79 | 2.28 | -3.54 | -0.73 | 1.97 | -0.34 | -4.55 | -2.32 | 1.71 | -2.29 | -0.81 | -2.81 | -0.41 | n/a |
PS Ratio | 1.01K | 1.13K | 794.47 | 1.42K | n/a | 2.82K | 1.63K | 3.7K | 3.25K | 5.29K | 12.14K | 12.2K | n/a | 12.97K | 239.13 |
PB Ratio | 5.02 | 4.24 | 3.59 | 3.16 | 3.21 | 3.43 | 4.02 | 6.74 | 8.66 | 7.70 | 11.40 | 12.99 | 13.19 | 19.79 | 61.53 |
P/FCF Ratio | -26.49 | -35.65 | -24.23 | -26.39 | -21.07 | -22.69 | -23.55 | -34.17 | -30.61 | -44.72 | -54.22 | -67.96 | -96.73 | -83.07 | -180.12 |
P/OCF Ratio | -26.62 | -35.75 | -24.25 | -26.46 | -21.13 | -22.76 | -23.62 | -34.18 | -30.62 | -44.73 | -54.22 | -67.96 | -96.75 | -83.11 | -181.40 |
OCF/S Ratio | -4.52K | -2.29K | -15.05K | -15.79K | -24.46K | -28.09K | -15.25K | -415.64K | -436.51K | -432.88K | -432.68K | -31.16K | -1.37K | -15.6K | -131.82 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.04 | 0.13 | 0.38 |
Quick Ratio | 25.19 | 25.18 | 25.11 | 27.79 | 30.93 | 37.29 | 44.04 | 38.62 | 34.27 | 22.37 | 7.88 | 6.87 | 3.18 | 9.54 | 9.78 |
Current Ratio | 25.23 | 25.22 | 25.14 | 27.80 | 30.93 | 37.29 | 44.04 | 38.62 | 34.27 | 22.37 | 7.88 | 6.87 | 3.18 | 9.54 | 9.78 |
Asset Turnover | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | n/a | 0 | 0.18 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -35.25K | -27.95 |
Return on Equity | -6.26% | -5.89% | -5.73% | -5.44% | -4.80% | -4.11% | -3.63% | -4.73% | -5.25% | -4.40% | -5.38% | -4.88% | -4.54% | -28.31% | -31.90% |
Return on Assets | -5.95% | -5.61% | -5.46% | -5.21% | -4.64% | -4% | -3.54% | -4.51% | -4.98% | -4.14% | -3.41% | -2.81% | -1.89% | -23.99% | -21.88% |
Return on Invested Capital | -7.01% | -6.75% | -6.73% | -6.43% | -5.92% | -5.28% | -4.77% | -6.02% | -6.45% | -5.29% | -4.30% | -3.40% | -2.19% | -24.91% | -22.62% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -108.22% | -48.41% | -13.19K% | -14.62K% | -26.01K% | -30.14K% | -16.94K% | -15.57K% | -36.76K% | -32.62K% | -33.63K% | -33.56K% | -1.31K% | 92.15% | 99.90% |
Net Profit Margin | -4.2K% | -2.49K% | -17.67K% | -18.96K% | -30.17K% | -34.43K% | -18.66K% | -419.82K% | -440.65K% | -436.39K% | -436.71K% | -33.81K% | -1.49K% | -18.56K% | -123.95% |
Pretax Profit Margin | -4.2K% | -2.49K% | -17.67K% | -18.96K% | -30.17K% | -34.43K% | -18.66K% | -419.82K% | -440.65K% | -436.39K% | -436.71K% | -33.81K% | -1.49K% | -18.56K% | -123.95% |
Operating Profit Margin | -4.69K% | -2.82K% | -21.58K% | -23.14K% | -38.83K% | -44.65K% | -25.42K% | -496.64K% | -519.19K% | -513.37K% | -513.56K% | -40.26K% | -1.67K% | -18.45K% | -121.70% |
FCF Margin | -4.55K% | -3.06K% | -20.08K% | -21.08K% | -32.64K% | -28.12K% | -15.26K% | -415.64K% | -436.5K% | -577.15K% | -576.89K% | -62.28K% | -4.12K% | -15.61K% | -132.76% |
EBITDA Margin | -4.17K% | -2.46K% | -17.64K% | -18.95K% | -30.15K% | -34.4K% | -18.65K% | -419.71K% | -440.53K% | -436.28K% | -436.59K% | -33.79K% | -1.49K% | -18.55K% | -119.50% |
Add to Watchlist
Select watchlists to add or remove CGON